178 related articles for article (PubMed ID: 27456244)
1. Angiotensin (1-7) and Alamandine: Similarities and differences.
Qaradakhi T; Apostolopoulos V; Zulli A
Pharmacol Res; 2016 Sep; 111():820-826. PubMed ID: 27456244
[TBL] [Abstract][Full Text] [Related]
2. Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.
Tesanovic S; Vinh A; Gaspari TA; Casley D; Widdop RE
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1606-13. PubMed ID: 20448208
[TBL] [Abstract][Full Text] [Related]
3. Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes.
Jesus ICG; Scalzo S; Alves F; Marques K; Rocha-Resende C; Bader M; Santos RAS; Guatimosim S
Am J Physiol Cell Physiol; 2018 Jun; 314(6):C702-C711. PubMed ID: 29443552
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways.
Xiao X; Zhang C; Ma X; Miao H; Wang J; Liu L; Chen S; Zeng R; Chen Y; Bihl JC
Exp Cell Res; 2015 Aug; 336(1):58-65. PubMed ID: 26101159
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice.
Stegbauer J; Potthoff SA; Quack I; Mergia E; Clasen T; Friedrich S; Vonend O; Woznowski M; Königshausen E; Sellin L; Rump LC
Br J Pharmacol; 2011 Jul; 163(5):974-83. PubMed ID: 21371005
[TBL] [Abstract][Full Text] [Related]
6. The possible role of a bacterial aspartate β-decarboxylase in the biosynthesis of alamandine.
Jha S; Speth RC; Macheroux P
Med Hypotheses; 2020 Nov; 144():110038. PubMed ID: 32758880
[TBL] [Abstract][Full Text] [Related]
7. Reduction of angiotensin A and alamandine vasoactivity in the rabbit model of atherogenesis: differential effects of alamandine and Ang(1-7).
Habiyakare B; Alsaadon H; Mathai ML; Hayes A; Zulli A
Int J Exp Pathol; 2014 Aug; 95(4):290-5. PubMed ID: 24953785
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-(1-7) and Alamandine on Experimental Models of Hypertension and Atherosclerosis.
de Souza-Neto FP; Carvalho Santuchi M; de Morais E Silva M; Campagnole-Santos MJ; da Silva RF
Curr Hypertens Rep; 2018 Mar; 20(2):17. PubMed ID: 29541937
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-(1-7) Selectively Induces Relaxation and Modulates Endothelium-Dependent Dilation in Mesenteric Arteries of Salt-Fed Rats.
Raffai G; Lombard JH
J Vasc Res; 2016; 53(1-2):105-118. PubMed ID: 27676088
[TBL] [Abstract][Full Text] [Related]
10. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
[TBL] [Abstract][Full Text] [Related]
11. An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemia.
Fraga-Silva RA; Costa-Fraga FP; Savergnini SQ; De Sousa FB; Montecucco F; da Silva D; Sinisterra RD; Mach F; Stergiopulos N; da Silva RF; Santos RA
J Sex Med; 2013 Oct; 10(10):2430-42. PubMed ID: 23890028
[TBL] [Abstract][Full Text] [Related]
12. Vascular Actions of Angiotensin 1-7 in the Human Microcirculation: Novel Role for Telomerase.
Durand MJ; Zinkevich NS; Riedel M; Gutterman DD; Nasci VL; Salato VK; Hijjawi JB; Reuben CF; North PE; Beyer AM
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1254-62. PubMed ID: 27079876
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Mas1 Receptor-Mediated Signaling in the Vascular Endothelium.
Hoffmann BR; Stodola TJ; Wagner JR; Didier DN; Exner EC; Lombard JH; Greene AS
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):433-445. PubMed ID: 28082260
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO mice.
Yang G; Istas G; Höges S; Yakoub M; Hendgen-Cotta U; Rassaf T; Rodriguez-Mateos A; Hering L; Grandoch M; Mergia E; Rump LC; Stegbauer J
Pflugers Arch; 2018 Apr; 470(4):661-667. PubMed ID: 29352340
[TBL] [Abstract][Full Text] [Related]
15. Alamandine but not angiotensin-(1-7) produces cardiovascular effects at the rostral insular cortex.
Marins FR; Oliveira AC; Qadri F; Motta-Santos D; Alenina N; Bader M; Fontes MAP; Santos RAS
Am J Physiol Regul Integr Comp Physiol; 2021 Sep; 321(3):R513-R521. PubMed ID: 34346721
[TBL] [Abstract][Full Text] [Related]
16. Swimming training improves the vasodilator effect of angiotensin-(1-7) in the aorta of spontaneously hypertensive rat.
Silva DM; Gomes-Filho A; Olivon VC; Santos TM; Becker LK; Santos RA; Lemos VS
J Appl Physiol (1985); 2011 Nov; 111(5):1272-7. PubMed ID: 21903888
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review.
Ferreira AJ; Bader M; Santos RA
Expert Opin Ther Pat; 2012 May; 22(5):567-74. PubMed ID: 22510001
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-(1-7) inhibits sodium transport via Mas receptor by increasing nitric oxide production in thick ascending limb.
Dibo P; Marañón RO; Chandrashekar K; Mazzuferi F; Silva GB; Juncos LA; Juncos LI
Physiol Rep; 2019 Mar; 7(5):e14015. PubMed ID: 30839176
[TBL] [Abstract][Full Text] [Related]
19. Alamandine: a new member of the angiotensin family.
Villela DC; Passos-Silva DG; Santos RA
Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):130-4. PubMed ID: 24389733
[TBL] [Abstract][Full Text] [Related]
20. Alamandine reduces leptin expression through the c-Src/p38 MAP kinase pathway in adipose tissue.
Uchiyama T; Okajima F; Mogi C; Tobo A; Tomono S; Sato K
PLoS One; 2017; 12(6):e0178769. PubMed ID: 28591164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
